Cargando…
Bedside anti-Xa measurement for therapeutic assessment of a prophylactic anticoagulation regimen
Autores principales: | Dewulf, B, Herck, I, De Somer, F, Francois, K, Decruyenaere, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642634/ http://dx.doi.org/10.1186/cc12286 |
Ejemplares similares
-
Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 – The role of anti-Xa monitoring
por: Kofteridis, Diamantis P., et al.
Publicado: (2021) -
Acute kidney injury in cardiorenal syndrome type 1: a meta-analysis
por: Vandenberghe, W, et al.
Publicado: (2014) -
Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006) -
Assessment of anti-factor Xa activity in critically ill COVID-19 patients receiving three different anticoagulation regimens
por: Hamad, Mohammed A, et al.
Publicado: (2021) -
Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)